Company intelligence / Profile preview

Ibpharco

Ownership: Private
Development stage: Commercial

Overview

Ibpharco is a pharmaceutical manufacturer based in Vietnam, primarily engaged in the production and distribution of generic medicines and over-the-counter pharmaceuticals. The company serves both domestic and regional markets with a portfolio focused on essential medicines. No clinical-stage innovative drug development was identified.

Modalities: Small molecules
Industry: Biotech

Drug pipeline

1 asset

grape seed tannin extract

Commercial

Indications: Animal feed supplement

Beyond the preview

Go deeper on Ibpharco.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ibpharco.

Explore the full profile